Zevra Therapeutics (ZVRA) said Tuesday it will be added to the Nasdaq Biotechnology Index as part of the annual reconstitution of Nasdaq indexes, effective on Monday.
The Nasdaq Biotechnology Index tracks listed securities in either biotechnology or pharmaceutical fields.